Market research
CALA Calithera Biosciences Inc
PINK USD Financial Services
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 487
- P/E ratio
- Not available
- Analyst target
- 5
- Dividend yield
- Not available
- Beta
- -1.22
Profile
Company facts
- Exchange
- PINK
- Currency
- USD
- Sector
- Financial Services
- Industry
- Shell Companies
- ISIN
- US13089P5070
- Market cap
- 487
- P/E ratio
- Not available
- Analyst target
- 5
- Dividend yield
- Not available
- Beta
- -1.22
About
About Calithera Biosciences Inc
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CALA discussion.
5 years, 4 months ago
Calithera Biosciences, Inc is currently in a long term downtrend where the price is trading 39.1% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Calithera Biosciences, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 3.9% to $-23M since the same quarter in the previous year.
Finally, its free cash flow fell by 25.2% to $-23M since the same quarter in the previous year.
Based on the above factors, Calithera Biosciences, Inc gets an overall score of 1/5.